Tradestie Institutional Equity Comparison Engine

NVS vs SGP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (3โ€“1 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Options & Structure while SGP counters with relative strength in Momentum & Technical. Fundamentally, NVS trades at 16.1x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus SGP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against SGP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
NVS 16.1x vs SGP N/M Fwd P/E
Growth & Margin Winner NVS
Op Margin 34.0% vs N/A ยท YoY +4.7% vs N/A
Momentum & Technical Winner SGP
1Y +21.4% vs +22.1% ยท 52W Pos 78% vs 66%
Options & Structure Winner NVS
UNCLASSIFIED (6th %ile IV) vs UNCLASSIFIED (N/A IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$160.20
-0.19% 1D
Market Cap $303.1B
1M Return +6.36%
1Y Return +21.45%
Forward P/E 16.1x
Unified AI Score
43.7 / 100 HOLD
Tech 37.0 Fund 37.0 Flow 50.0 Mom 21.1
SGP US Equity
SGP
Institutional Equity
$32.24
-1.95% 1D
Market Cap N/A
1M Return +34.33%
1Y Return +22.12%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 15.0 Fund 45.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +21.45% SGP +22.12% Spread: +19.7 pp (SGP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% SGP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs SGP. Trailing 12-month operating profitability (NVS 34.0% vs SGP N/A) and valuation multiples (NVS 16.1x vs SGP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (10) vs SGP (0)
Institutional Metric NVS SGP Criterion Row Winner
Market Capitalization Scale $303.1B N/A Larger Scale NVS
Trailing P/E Ratio Valuation 30.6x N/M Lower Multiple NVS
Forward P/E Ratio Valuation 16.1x N/M Lower Multiple NVS
Revenue Growth (YoY) Growth +4.7% N/A Higher Growth NVS
Operating Margin (TTM) Profitability 34.0% N/A Higher Margin NVS
Net Profit Margin Profitability 17.5% N/A Higher Margin NVS
Return on Equity (ROE) Capital Efficiency 24.3% N/A Higher ROE NVS
52-Week Range Position Momentum 78% ($123โ€“$170) 66% ($17โ€“$40) Stronger Trend NVS
Beta / 30D Volatility Risk Regime 0.31ฮฒ ยท 27% Vol 1.38ฮฒ ยท 70% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 43.7 / 100 (HOLD) 39.3 / 100 (SELL) Higher Composite NVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs SGP Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SGP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor SGP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.